The Cortex Labs Nootropics Podcast

Ep 94: Study: Aniracetam straight for 12 months


Listen Later

Study data: (LINK TO STUDY HERE) Introduction: Dementia constitutes an increasingly prevalent cognitive disorder with serious socioeconomic implications. Aims: In the present study, we aimed to evaluate the efficacy of aniracetam, either as monotherapy or combined with cholinesterase inhibitors (ChEIs), in terms of several neuropsychological parameters, in a considerable number of patients with dementia. Results: In our prospective, open?label study, […]
...more
View all episodesView all episodes
Download on the App Store

The Cortex Labs Nootropics PodcastBy Cortex Labs